Form 8-K Edwards Lifesciences For: Oct 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Edwards Lifesciences (EW) PT Raised to $122 at Oppenheimer
October 28, 2021 7:46 AM EDTOppenheimer analyst Suraj Kalia raised the price target on Edwards Lifesciences (NYSE: EW) to $122.00 (from $120.00) while maintaining an Outperform rating.
The analyst commented, "Edwards reported 3Q21 revenues of $1.31B, slightly behind our/consensus' $1.34B/$1.32B estimates, but within guidance of $1.291.37B. TAVR... More
Edwards Lifesciences (EW) PT Raised to $129 at Stifel
October 28, 2021 6:42 AM EDTStifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $129.00 (from $120.00) while maintaining a Buy rating.
The analyst commented, "Despite pockets of OUS TAVR strength/recovery, US Covid impacts pushed 3Q21 revenues to $1.31B, just below Street... More



